异基因造血干细胞移植后的免疫学随访 (SIA-CSH)
Description of the evolution of the biological characteristics of immune blood populations and biomarkers of interest in patients who have received allogeneic hematopoietic stem cell transplantation.
研究概览
地位
条件
详细说明
a more in-depth analysis of the different immune cell sub-populations as well as serum markers (cytokines) would provide a better understanding of post-allograft immune reconstitution mechanisms and identify potential immunologic biomarkers predictive of GVH or relapse.
研究类型
注册 (估计的)
联系人和位置
学习地点
-
-
Bouches-du Rhône
-
Marseille、Bouches-du Rhône、法国、13009
- Institut Paoli-Calmettes
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
The study population is male and / or female over 18 years of age with hematologic malignancies receiving allogeneic hematopoietic stem cell transplantation and corresponding donors.
描述
Inclusion Criteria:
- Allogeneic hematopoietic stem cell transplant for hematological malignancy
- Patients 18 years of age or older
- Signed consent to participation
- Membership in a social security scheme, or beneficiary of such a scheme.
Exclusion Criteria:
- A person of legal age subject to a legal protection measure (major under guardianship, curatorship or court bail), or unable to express consent (language criteria included).
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Donor
In the case of a transplant from an intrafamily donor (genoid or haploid), we will also collect blood samples from the donor. |
In the case of a transplant from an intrafamily donor (genoid or haploid), we will also collect blood samples from the donor. A single blood sample of 28 mL (7 EDTA tubes) will be made. In order not to represent an additional sample for the donor, this sample will be taken before the mobilization of the hematopoietic stem cells, during the biological assessment required for the biological donation qualification. |
|
Receiver
Systematic longitudinal collection of blood samples for any patient receiving an allogeneic CSH transplant in our facility, regardless of donor category selected and type of graft used |
Some sampling times will be systematic, while others will only be performed in the presence of specific post-transplant clinical events (eg relapse, GVH ...). |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Evolution of the immune blood populations in patients who have received allogeneic hematopoietic stem cell transplantation.
大体时间:5 years after HSC transplantation
|
longitudinal study of the immune subpopulations of allografted patients for hematological malignancies. |
5 years after HSC transplantation
|
合作者和调查者
合作者
调查人员
- 首席研究员:Raynier Devillier, MD, PhD、Institut Paoli-Calmettes
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.